Literature DB >> 9113508

Gene transfer to the intestinal tract: a new approach using selective injection of the superior mesenteric artery.

T J Sferra1, D McNeely, P R Johnson.   

Abstract

Gene transfer to the intestinal tract has many potential applications, including complementation of single gene disorders, genetic immunization, and ectopic production of therapeutic molecules. Because the intralumenal approach to vector administration has not been highly successful, we tested whether the circulation can be used as a route to transfer genes to intestinal cells. The superior mesenteric artery (SMA) and vein (SMV) of adult Lewis rats were isolated and an adenoviral vector expressing the Escherichia coli LacZ gene was injected into the SMA. In one set of experiments, both vessels remained patent throughout the entire procedure. In a second group of animals, both vessels were occluded by clamping the SMA 1 cm distal to the injection site and the SMV proximal to the portal vein. In the absence of vascular clamps, gene transfer was evident throughout the small bowel, localized near the serosal surface within the muscularis propria. Occlusion of the SMA and SMV limited gene delivery to a short segment of bowel and shifted beta-galactosidase activity toward the mucosal surface. At the level of microscopy, most of the transduction events were in the lamina propria; transduced mucosal epithelial cells were occasionally observed. These data demonstrate that intestinal gene transfer can be accomplished through the circulation, and that targeting specific regions is feasible.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9113508     DOI: 10.1089/hum.1997.8.6-681

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  7 in total

1.  Mechanistic studies on nonviral gene delivery to the intestine using in vitro differentiated cell culture models and an in vivo rat intestinal loop.

Authors:  Sally-Ann Cryan; Caitriona M O'Driscoll
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

2.  Improved gene delivery to intestinal mucosa by adenoviral vectors bearing subgroup B and d fibers.

Authors:  S Lecollinet; F Gavard; M J E Havenga; O B Spiller; A Lemckert; J Goudsmit; M Eloit; J Richardson
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

3.  Interleukin 10 gene transfer prevents experimental colitis in rats.

Authors:  G Barbara; Z Xing; C M Hogaboam; J Gauldie; S M Collins
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

4.  Gene delivery to intestinal epithelial cells in vitro and in vivo with recombinant adeno-associated virus types 1, 2 and 5.

Authors:  Steven Polyak; Cathryn Mah; Stacy Porvasnik; John-David Herlihy; Martha Campbell-Thompson; Barry J Byrne; John F Valentine
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

Review 5.  Targeting the gastrointestinal tract with viral vectors: state of the art and possible applications in research and therapy.

Authors:  Roeland Buckinx; Jean-Pierre Timmermans
Journal:  Histochem Cell Biol       Date:  2016-09-24       Impact factor: 2.531

6.  Reversal of experimental colitis disease activity in mice following administration of an adenoviral IL-10 vector.

Authors:  Makoto Sasaki; J Michael Mathis; Merilyn H Jennings; Paul Jordan; Yuping Wang; Tomoaki Ando; Takashi Joh; J Steven Alexander
Journal:  J Inflamm (Lond)       Date:  2005-10-31       Impact factor: 4.981

7.  Transfection of IL-10 expression vectors into endothelial cultures attenuates alpha4beta7-dependent lymphocyte adhesion mediated by MAdCAM-1.

Authors:  Makoto Sasaki; Paul Jordan; Jeff Houghton; Xianmin Meng; Makoto Itoh; Takashi Joh; J Steven Alexander
Journal:  BMC Gastroenterol       Date:  2003-02-20       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.